Brief: Satsuma Pharmaceuticals Q1 Loss Per Share $0.68
12/05/2020 21:21
May 12 (Reuters) - Satsuma Pharmaceuticals Inc STSA.O :
* SATSUMA PHARMACEUTICALS REPORTS FIRST QUARTER 2020
FINANCIAL AND
BUSINESS RESULTS
* Q1 LOSS PER SHARE $0.68
* WELL-CAPITALIZED WITH CASH, CASH EQUIVALENTS, AND
MARKETABLE
SECURITIES OF $104.1 MILLION AT END OF Q1 2020
* NET LOSS FOR Q1 2020 WAS $11.8 MILLION, OR $0.68 PER
COMMON
SHARE
Source text for Eikon: ID:nGNX4h04G0
Further company coverage: STSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon